Work

Treosulfan/fludarabine: a new conditioning regimen in allogeneic transplantation.

Year: 2004

Type: article

Study design: Clinical Trial

Source: PubMed

DOI: 10.1007/s00277-004-0850-2

Authors: J Casper, W Knauf, I Blau, T Ruutu, L Volin, H Wandt, K Schafer-Eckart, J Holowiecki, S Giebel, J Aschan, A Zander, N Kroger, G Doelken, M Freund

Institution: University of Rostock

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Cancer Institute, National Institute of Nursing Research, National Institute of General Medical Sciences

Awards: Immunoglobulin Gene Arrangement/Expression in Leukemia, G1860110607, BCI2 Antisense Against Chemoresistance in Elderly AML, North Shore CCOP, Phase I Trials of Anti-Cancer Agents, Cancer and Leukemia Group B, LARG, A Novel Leukemia Associated Guanine Exhange Factor, Cancer and Leukemia Group B - Leukemia Correlative Sciences, CHILDRENS CANCER GROUP CHAIRMANS AWARD, G438107773, G4956614918, Cancer and Leukemia Group B, Cancer and Leukemia Group B, ALL therapy and developing brains: MRI measures, genetic factors and cognition, SLEEP, FATIGUE, AND DEXAMETHOSONE IN CHILDHOOD CANCER, CANCER AND LEUKEMIA GROUP B, PAAR-Pharmacogenomics of Anticancer Agents Research Group, PHARMACODYNAMICS OF ANTILEUKEMIC AGENTS IN CHILDREN, CANCER AND LEUKEMIA GROUP B, Cancer and Leukemia Group B, Cancer and Leukemia Group B - The Ohio State University, Cancer Center Support Grant, Cancer Center Support Grant (CCSG)

OpenAlex ID: W78232097

FWCI: 0.853

Cites:

Cited by: 24

Related to: 10